| Barbara Lynn Calvert, PHARMD | |
|
601 Broadway, Scottsbluff, NE 69361-3517 | |
| (308) 635-1444 | |
| Not Available |
| Full Name | Barbara Lynn Calvert |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 601 Broadway, Scottsbluff, Nebraska |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1386427649 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 18021 (Nebraska) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Lynn Calvert, PHARMD 1902 E 29th St, Scottsbluff, NE 69361-1847 Ph: (308) 641-2659 | Barbara Lynn Calvert, PHARMD 601 Broadway, Scottsbluff, NE 69361-3517 Ph: (308) 635-1444 |
News Archive
Fragile X syndrome is the most common form of inherited mental retardation, occurring in 1 in 3600 males and 1 in 4000 to 6000 females.
Johns Hopkins Bloomberg School of Public Health researchers say a new candidate vaccine against respiratory syncytial virus (RSV) made with a weakened version of the virus shows great promise at fighting the disease, the leading cause of hospitalization for children under the age of one in the U.S.
Receptos, a biopharmaceutical company, today announces grant of license and technology transfer to Ortho-McNeil-Janssen Pharmaceuticals, for Receptos's breakthrough GPCR crystal structure determination technology.
Warning pregnant mothers about fetal abnormalities before scans would only have caused additional distress
The U.S. Environmental Protection Agency (EPA), the National Institute of Environmental Health Sciences National Toxicology Program (NTP) and the National Institute of Health Chemical Genomics Center (NCGC) welcome the U.S. Food and Drug Administration (FDA) to the Tox21 collaboration. The Tox21 collaboration merges federal agency resources (research, funding and testing tools) to develop ways to more effectively predict how chemicals will affect human health and the environment. The collaboration was established in 2008 to develop models that will be able to better predict how chemicals will affect humans. FDA will provide additional expertise and chemical safety information to improve current chemical testing methods.
› Verified 4 days ago
Joseph M Ramirez, RP Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 802 E 27th St, Scottsbluff, NE 69361 Phone: 308-632-3822 Fax: 308-632-5381 | |
Dr. Craig Douglas Noe, PHARM. D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4021 Avenue B, Inpatient Pharmacy, Scottsbluff, NE 69361 Phone: 308-630-1262 Fax: 308-630-1860 | |
Dr. Tamora Emma Hood, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3911 Avenue B, Suite M-200, Scottsbluff, NE 69361 Phone: 308-630-1900 Fax: 308-630-1969 | |
Mr. Randall Wilbert Reznor, R.PH. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 4021 Avenue B, Regional West Medical Center, Scottsbluff, NE 69361 Phone: 308-630-1262 | |
Collin Lee Townsend, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3322 Avenue I, Scottsbluff, NE 69361 Phone: 308-632-3767 | |
Brooke Heine, PHARM.D. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3322 Avenue I, Scottsbluff, NE 69361 Phone: 308-632-3767 | |
Mrs. Anne E Bowman, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3911 Avenue B, Suite M200, Scottsbluff, NE 69361 Phone: 308-630-1944 Fax: 308-630-1969 |